Renal denervation offers a potentially transformative and minimally invasive option for treating hypertension. With this ...

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

Albany, NY (WRGB) — Albany Medical Center is now offering a new procedure aimed at helping patients with resistant hypertension, a condition where traditional medications fail to adequately lower ...

High blood pressure has been one of the biggest issues for Americans, not only is it difficult to control but also only 23% of people with high blood pressure actually achieve their treatment ...

Boston Scientific Corp. agreed to acquire Sonivie Ltd., developer of a therapeutic intravascular ultrasound system for denervation to treat resistant hypertension, pulmonary hypertension and chronic ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ultrasound-based therapy for stubbornly high blood pressure. The acquisition sets up ...

More research is needed on alcohol-mediated perivascular renal sympathetic denervation for treating resistant hypertension before it can be used in the NHS.

The move aims to broaden interventional cardiology therapies with ultrasound-based renal denervation therapy to treat hypertension. The transaction is expected to be completed in the first half of ...

Boston Scientific, Inc. BSX has signed a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that developed the TIVUS Intravascular Ultrasound System. The company ...

Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment.